IL6 and lung carcinoma: IL-6 (2nd generation) showed the highest odds ratio of 5.09 (95% CI: 2.38–9.24, p < 0.001), implying that patients with IL-6 levels above 25 pg/mL have a 5.09 times higher risk of lung cancer compared to those with lower levels.